bioRxivBiochemistryPreprint
Revealing the unexpected interplay between the Proteasome Activator PA200 and the immunoproteasome
Dušan ŽivkovićiD, Fatme Mourtada, Angélique Sanchez DafuniD, Ayse Seda YazgiliiD, Marijke JansmaiD, Przemysław GrygieriD, Michał RawskiiD, Anna CzarnaiD, Stefan BohniD, Krzysztof M. ŻakiD, Norbert ReilingiD, Linda Zemke, Kai GuoiD, Jürgen BehriD, Odile Burlet‐SchiltziD, Grzegorz M. PopowicziD, Julien MarcouxiD, Silke MeinersiD, Marie‐Pierre BousquetiD
Abstract
The proteasome activator PA200 binds to the catalytic core of the proteasome, the 20S, and activates its proteolytic activities. The cellular function of PA200 is poorly understood and appears to be cell type and differentiation specific. Recent evidence suggests that PA200 not only binds to the standard 20S (s20S) proteasome but also to the specialized immunoproteasome (i20S) which plays a key role in anti-viral and anti-tumor immunity. We here investigated the interaction of PA200 and the immunoproteasome in detail. We show the very first cryo-EM structures of the singly- and doubly-capped i20S-PA200 complexes that revealed no major difference regarding the first binding event of PA200 to the i20S vs. the s20S. However, first PA200 binding triggered a subtle and long range allosteric bending of the i20S barrel which was not seen in the s20S-PA200 complexes. This resulted in major structural rearrangements in the opposite unbound ring - the displacement of atoms up to 5.4 [A] and the increase in its outer diameter - thereby increasing the occupancy of the second PA200 binding site. Mass photometry confirmed higher occupancy of PA200 to the i20S versus the s20S. Binding of PA200 to the i20S enhanced proteasomal activation compared to the s20S. Co-expression of PA200 and the i20S in cells and tissues, however, is restricted but their interaction is favored upon co-expression. The expression of PA200 and the catalytic subunits of the i20S is differentially regulated depending on the cellular context. Our data also suggest that PA200 has the potential to regulate i20S gene expression whereas the i20S has no effects on PA200 expression. Overall, this work sheds new light on the interaction of PA200 with the i20S from a structural, mechanistic and cellular point of view. Importantly, we identify PA200 as a key regulator of the i20S whenever PA200 and the catalytic subunits of the i20S are co-expressed in the same cell.
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cryo-EM of mammalian PA28αβ-iCPimmunoproteasome reveals a distinct mechanism of proteasome activation by PA28αβ
- PIP30/FAM192A is a novel regulator of the nuclear proteasome activator PA28gamma
B. Jonik-Nowak, T. Menneteau, … O. Coux·bioRxiv·Mar 27, 2018
- Resolving the Activation Mechanism of the Human 20S Proteasome
Bryan D. Ryder, N. Yan, … Jason E. Gestwicki·bioRxiv·Apr 15, 2026
- Conformational maps of human 20S proteasomes reveal PA28- and immuno-dependant inter-ring crosstalks
J. Lesne, M. Locard-Paulet, … J. Marcoux·bioRxiv·May 5, 2020
- PI31 is a positive regulator of 20S immunoproteasome assembly
Jason Wang, Abbey Kjellgren, George Demartino·Journal of Cell SciencePeer-reviewed·May 8, 2025
- Differential interactions of the proteasome inhibitor PI31 with constitutive and immuno-20S proteasomes
J. Wang, A. Kjellgren, G. N. DeMartino·bioRxiv·Dec 11, 2023